chr6-43778432-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_003376.6(VEGFA):​c.856-28C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.291 in 1,609,198 control chromosomes in the GnomAD database, including 71,541 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.23 ( 4923 hom., cov: 32)
Exomes 𝑓: 0.30 ( 66618 hom. )

Consequence

VEGFA
NM_003376.6 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.00500

Publications

67 publications found
Variant links:
Genes affected
VEGFA (HGNC:12680): (vascular endothelial growth factor A) This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site. The levels of VEGF are increased during infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), thus promoting inflammation by facilitating recruitment of inflammatory cells, and by increasing the level of angiopoietin II (Ang II), one of two products of the SARS-CoV-2 binding target, angiotensin-converting enzyme 2 (ACE2). In turn, Ang II facilitates the elevation of VEGF, thus forming a vicious cycle in the release of inflammatory cytokines. [provided by RefSeq, Jun 2020]
VEGFA Gene-Disease associations (from GenCC):
  • congenital heart disease
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 6-43778432-C-T is Benign according to our data. Variant chr6-43778432-C-T is described in ClinVar as Benign. ClinVar VariationId is 1259260.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.384 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003376.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VEGFA
NM_003376.6
MANE Select
c.856-28C>T
intron
N/ANP_003367.4
VEGFA
NM_001025366.3
c.856-28C>T
intron
N/ANP_001020537.2P15692-14
VEGFA
NM_001025367.3
c.856-28C>T
intron
N/ANP_001020538.2P15692-16

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VEGFA
ENST00000672860.3
MANE Select
c.856-28C>T
intron
N/AENSP00000500082.3P15692-13
VEGFA
ENST00000372055.9
TSL:1
c.856-28C>T
intron
N/AENSP00000361125.5P15692-14
VEGFA
ENST00000425836.9
TSL:1
c.856-28C>T
intron
N/AENSP00000388465.4A0A0A0MSH5

Frequencies

GnomAD3 genomes
AF:
0.232
AC:
35240
AN:
152062
Hom.:
4921
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0658
Gnomad AMI
AF:
0.191
Gnomad AMR
AF:
0.289
Gnomad ASJ
AF:
0.364
Gnomad EAS
AF:
0.398
Gnomad SAS
AF:
0.250
Gnomad FIN
AF:
0.228
Gnomad MID
AF:
0.250
Gnomad NFE
AF:
0.300
Gnomad OTH
AF:
0.263
GnomAD2 exomes
AF:
0.290
AC:
72129
AN:
248984
AF XY:
0.290
show subpopulations
Gnomad AFR exome
AF:
0.0581
Gnomad AMR exome
AF:
0.331
Gnomad ASJ exome
AF:
0.365
Gnomad EAS exome
AF:
0.400
Gnomad FIN exome
AF:
0.231
Gnomad NFE exome
AF:
0.310
Gnomad OTH exome
AF:
0.295
GnomAD4 exome
AF:
0.297
AC:
433047
AN:
1457018
Hom.:
66618
Cov.:
31
AF XY:
0.297
AC XY:
214996
AN XY:
725010
show subpopulations
African (AFR)
AF:
0.0519
AC:
1733
AN:
33380
American (AMR)
AF:
0.325
AC:
14463
AN:
44480
Ashkenazi Jewish (ASJ)
AF:
0.366
AC:
9561
AN:
26096
East Asian (EAS)
AF:
0.415
AC:
16436
AN:
39614
South Asian (SAS)
AF:
0.247
AC:
21222
AN:
86072
European-Finnish (FIN)
AF:
0.234
AC:
12443
AN:
53248
Middle Eastern (MID)
AF:
0.278
AC:
1578
AN:
5672
European-Non Finnish (NFE)
AF:
0.306
AC:
338640
AN:
1108214
Other (OTH)
AF:
0.282
AC:
16971
AN:
60242
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
15152
30304
45457
60609
75761
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11082
22164
33246
44328
55410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.232
AC:
35250
AN:
152180
Hom.:
4923
Cov.:
32
AF XY:
0.230
AC XY:
17123
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.0658
AC:
2734
AN:
41566
American (AMR)
AF:
0.289
AC:
4414
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.364
AC:
1263
AN:
3472
East Asian (EAS)
AF:
0.398
AC:
2054
AN:
5160
South Asian (SAS)
AF:
0.249
AC:
1201
AN:
4824
European-Finnish (FIN)
AF:
0.228
AC:
2410
AN:
10590
Middle Eastern (MID)
AF:
0.252
AC:
74
AN:
294
European-Non Finnish (NFE)
AF:
0.300
AC:
20361
AN:
67958
Other (OTH)
AF:
0.267
AC:
565
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1343
2685
4028
5370
6713
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
370
740
1110
1480
1850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.273
Hom.:
12159
Bravo
AF:
0.234
Asia WGS
AF:
0.270
AC:
937
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
14
DANN
Benign
0.82
PhyloP100
0.0050
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3025000; hg19: chr6-43746169; COSMIC: COSV57879845; COSMIC: COSV57879845; API